|
(PQA1) Molecular Mechanism of Metformin in Cancer
|
1R21CA184704-01
|
$190,313
|
DAI, CHENGKAI
|
JACKSON LABORATORY
|
|
(PQB-4) Opposing Effects of the SASP in Cancer Progression
|
1R01CA184572-01
|
$329,925
|
HERBIG, UTZ
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
(PQB2) Identification of Tumor-Derived Activators of Anti-Cancer Immune Responses
|
1R21CA190072-01
|
$218,296
|
SUNWOO, JOHN
|
STANFORD UNIVERSITY
|
|
(PQC2) Resistance to fluid shear stress: a novel biomarker of cancer cells
|
5R21CA179981-02
|
$159,287
|
HENRY, MICHAEL
|
UNIVERSITY OF IOWA
|
|
(PQD1) Clonal heterogeneity and targeted therapy resistance in melanoma
|
1R01CA185072-01
|
$382,030
|
SEKULIC, ALEKSANDAR
|
MAYO CLINIC ARIZONA
|
|
(PQD1) Evolution of vemurafenib resistance in circulating melanoma cells
|
1R01CA185151-01
|
$603,086
|
NOVINA, CARL
|
DANA-FARBER CANCER INST
|
|
(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis
|
1R01CA185189-01
|
$481,506
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQD5) Predicting Anti-Cancer Efficacy through Tumor Profiling
|
1R01CA185353-01
|
$405,890
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
A comparison of interventions to teach melanoma patients' skin self-examination
|
5R01CA154908-04
|
$514,641
|
ROBINSON, JUNE
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
A High-Throughput Model for Human Melanoma
|
2R01CA121118-06A1
|
$250,535
|
HOLMEN, SHERI
|
UNIVERSITY OF UTAH
|
|
A microRNA based prognostic service that predicts melanoma metastasis likelihood
|
1R43CA183092-01
|
$199,654
|
KURTH, ISABEL
|
RGENIX, INC.
|
|
A novel NKG2D-specific BiTE cancer immunotherapy
|
5R01CA164178-02
|
$326,066
|
SENTMAN, CHARLES
|
DARTMOUTH COLLEGE
|
|
A novel preclinical model of spontaneous metastasis
|
ZIA BC 011167
|
$420,465
|
Merlino, Glenn
|
CCR (NCI)
|
|
A NOVEL STRATEGY FOR THE TREATMENT OF MELANOMA
|
5R03CA175660-02
|
$66,120
|
XU, MAI
|
WASHINGTON UNIVERSITY
|
|
A Patient Oriented Research Program for Surgical Oncologists
|
5K24CA138709-05
|
$113,392
|
GOYDOS, JAMES
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
A Platform for Real-time Drug Profiling of Patient-Derived Melanomas
|
1F32CA180569-01A1
|
$55,094
|
NUSSBAUM, DANIEL
|
DUKE UNIVERSITY
|
|
A research and training program for junior clinicians in treating metastatic mela
|
5K24CA172123-02
|
$156,084
|
KLUGER, HARRIET
|
YALE UNIVERSITY
|
|
A role for c-Abl/Arg in melanoma progression
|
5R01CA166499-03
|
$299,345
|
PLATTNER, RINA
|
UNIVERSITY OF KENTUCKY
|
|
A Self-Regulation Approach to an Indoor Tanning Intervention for Frequent Users
|
1K07CA175115-01A1
|
$137,183
|
STAPLETON, JEROD
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
A Small Molecule to Activate Tumor Immunity after PLX403 in V600E BRAF Melanoma
|
3R41CA174008-01A1S1
|
$160,721
|
JONES, BARRY
|
ARISAPH PHARMACEUTICALS, INC.
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-38S1
|
$74,997
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Accuracy in the Diagnosis of Melanoma & the Impact of Double Reading
|
5R01CA151306-04
|
$834,926
|
ELMORE, JOANN
|
UNIVERSITY OF WASHINGTON
|
|
Adaptive signaling exposes a therapeutic vulnerability in NRAS melanomas
|
1R21CA182020-01
|
$206,190
|
WEBER, MICHAEL
|
UNIVERSITY OF VIRGINIA
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$2,555,132
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Adoptive T cell Therapy of Melanoma Targeting NY-ESO-1
|
5R01CA104711-10
|
$301,062
|
YEE, CASSIAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
5U24CA180921-02
|
$626,118
|
CROWLEY, REBECCA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Advances in Melanoma: From Biology to Therapy
|
1R13CA189528-01
|
$4,000
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk
|
5R01CA134891-05
|
$501,986
|
HILLHOUSE, JOEL
|
EAST TENNESSEE STATE UNIVERSITY
|
|
An innovative, curriculum-based integrated sun exposure behavior intervention fo
|
5R01CA158407-03
|
$665,619
|
COCKBURN, MYLES
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
An Internet-Based Behavioral Intervention for Individuals Diagnosed with Melanoma
|
1R01CA171666-01A1
|
$507,030
|
COUPS, ELLIOT
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Analysis of cap-dependent translational repression by microRNAs in oncogensis
|
5R01CA140986-04
|
$317,009
|
NOVINA, CARL
|
DANA-FARBER CANCER INST
|
|
Analysis of the Signaling and Mechanical Cues Promoting Invasion in Melanoma
|
5U01CA155758-05
|
$272,428
|
LEVCHENKO, ANDRE
|
YALE UNIVERSITY
|
|
Analyzing the Efficacy of Galectin-1 Ligand Inhibition in Adoptive T cell Therapy
|
5F31CA171520-02
|
$34,366
|
SWEENEY, JENNA
|
HARVARD MEDICAL SCHOOL
|
|
Animal Model and Genotyping Core Support Facility
|
ZIC BC 011047
|
$1,184,484
|
DuBois, Wendy
|
CCR (NCI)
|
|
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
|
5R01CA092160-13
|
$289,149
|
TIGYI, GABOR
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,416,689
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Applied Molecular Pathology Laboratory
|
ZIC BC 011257
|
$158,649
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Arginase Production in Cancer: Evading Immune Response
|
5R01CA107974-09
|
$285,814
|
OCHOA, AUGUSTO
|
LSU HEALTH SCIENCES CENTER
|
|
Assessing Resident Physician Melanoma Detection Across Ethnic Groups
|
5R21CA176534-02
|
$166,721
|
HERNANDEZ, CLAUDIA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
ATF2 Oncogenic Addiction in Melanoma
|
5R01CA172017-02
|
$392,486
|
RONAI, ZE'EV
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
B7-H1 Signaling in Ovarian Cancer
|
5R01CA164122-03
|
$300,907
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
B7-H1/PD-1 modulation in cancer therapy
|
5R01CA142779-05
|
$443,937
|
PARDOLL, DREW
|
JOHNS HOPKINS UNIVERSITY
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,704,173
|
Custer, Mary
|
CCR (NCI)
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|